Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4-5 kdigo without renal replacement therapy: a double-blind randomized hebe-ckd trial

HIGHLIGHTS

• who: Fabio Solis-Jimenez from the Master and Doctorate Program in Health Sciences, Universidad Nacional Autu00f3noma de Mu00e9xico, Mexico City, Mexico have published the article: Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4-5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial, in the Journal: (JOURNAL) of June/18,/2019
• what: The aim of this study was to assess the efficacy and safety of treatment with plus in patients with chronic kidney disease (CKD) 4-5 Methods: A . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.